We are a regional biopharma company specializing in the commercialization of innovative biopharmaceutical products targeting severe and rare diseases.
Headquartered in Nicosia, Genesis Pharma (Cyprus) Ltd was founded with the mission to ensure that patients suffering from severe and rare diseases, have direct access to innovative branded medicines. Guided by this same mission, the company is operating through local subsidiaries in Sofia, Bulgaria (Genesis Pharma Bulgaria EOOD), Bucharest in Romania (Genesis Biopharma Romania SRL), Zagreb in Croatia (Genesis Pharma Adriatic d.o.o.) and Ljubljana in Slovenia (Genesis Biopharma SL d.o.o.), and is also covering neighboring countries in South East Europe as well as Malta.
The company has established long-term alliances with leading global biopharma companies and is responsible for a unique portfolio which includes innovative biopharmaceuticals that tackle severe and rare diseases. Its novel branded pharmaceutical products cover the therapeutic areas of Haematology, Oncology, Central Nervous System, Nephrology, Gastroenterology, Rheumatology-Dermatology as well as Rare Genetic Inherited diseases.
Genesis Pharma (Cyprus) Ltd is affiliated (sister company) to GENESIS Pharma SA in Athens, Greece.